Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
ACS Appl Mater Interfaces ; 11(35): 31627-31637, 2019 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-31412200

RESUMEN

The vascular transport of molecules, cells, and nanoconstructs is a fundamental biophysical process impacting tissue regeneration, delivery of nutrients and therapeutic agents, and the response of the immune system to external pathogens. This process is often studied in single-channel microfluidic devices lacking the complex tridimensional organization of vascular networks. Here, soft lithography is employed to replicate the vein system of a Hedera elix leaf on a polydimethilsiloxane (PDMS) template. The replica is then sealed and connected to an external pumping system to realize an authentically complex microvascular network. This satisfies energy minimization criteria by Murray's law and comprises a network of channels ranging in size from capillaries (∼50 µm) to large arterioles and venules (∼400 µm). Micro-PIV (micro-particle image velocimetry) analysis is employed to characterize flow conditions in terms of streamlines, fluid velocity, and flow rates. To demonstrate the ability to reproduce physiologically relevant transport processes, two different applications are demonstrated: vascular deposition of tumor cells and lysis of blood clots. To this end, conditions are identified to culture cells within the microvasculature and realize a confluent endothelial monolayer. Then, the vascular deposition of circulating breast (MDA-MB 231) cancer cells is documented throughout the network under physiologically relevant flow conditions. Firm cell adhesion mostly occurs in channels with low mean blood velocity. As a second application, blood clots are formed within the chip by mixing whole blood with a thrombin solution. After demonstrating the blood clot stability, tissue plasminogen activator (tPA) and tPA-carrying nanoconstructs (tPA-DPNs) are employed as thrombolytics. In agreement with previous data, clot dissolution is equally induced by tPA and tPA-DPNs. The proposed leaf-inspired chip can be efficiently used to study a variety of vascular transport processes in complex microvascular networks, where geometry and flow conditions can be modulated and monitored throughout the experimental campaign.


Asunto(s)
Materiales Biomiméticos , Fibrinolíticos/química , Hedera/anatomía & histología , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Dispositivos Laboratorio en un Chip , Hojas de la Planta/anatomía & histología , Trombosis/metabolismo , Activador de Tejido Plasminógeno/química , Transporte Biológico , Células Endoteliales de la Vena Umbilical Humana/patología , Humanos , Trombosis/patología
2.
Biomimetics (Basel) ; 2(1)2017 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-31105164

RESUMEN

A superhydrophobic behavior can be obtained by properly modifying the surface topography of Teflon or other fluorinated polymers having an inherent hydrophobic character. According to this strategy, we have micro/nanotextured Teflon both as plane material (sheets) and as three-dimensional (3D) object (spheres) with a single step plasma process. The obtained textured Teflon samples were compared with those made of pristine Teflon in air, in terms of repulsion of impacting water droplets, and underwater, in terms of air layer behavior under static and dynamic conditions. The latter case was investigated by subjecting the spheres to a vertical fall in water. Modified surfaces present nanofilaments on the top of micrometric vertical structures, which can increase the air retaining capacity, resulting in a biomimicry effect due to a similarity with the Salvinia molesta leaf. On this surface, repulsion of impacting water droplets can be as fast as previously reached only on heated solids. Also, the air layer over the modified spheres underwater is shown to play a role in the observed reduction of hydrodynamic drag onto the moving object.

3.
Mol Pharm ; 10(8): 3186-94, 2013 Aug 05.
Artículo en Inglés | MEDLINE | ID: mdl-23789777

RESUMEN

A large number of studies document the strong expression of aquaporin-1 (AQP1) in tumor microvessels and correlate this aberrant expression with higher metastatic potential and aggressiveness of the malignancy. Although small animal experiments have shown that the modulation of AQP1 expression can halt angiogenesis and induce tumor regression, effective and safe strategies for the tissue specific inhibition of AQP1 are still missing. Here, small interference RNA-chitosan complexes encapsulated in poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) are proposed for the intracellular delivery of siRNA molecules against AQP1. These NPs are coated with poly(vinyl alcohol) (PVA), to improve stability under physiological conditions, and demonstrate a diameter of 160 nm. The partial neutralization of the negatively charged siRNA molecules with the cationic chitosan enhances the loading by 5-fold, as compared to that of the free siRNA molecules, and allows one to modulate the release kinetics in the pH-dependent manner. At pH = 7.4, mimicking the conditions found in the systemic circulation, only the 40% of siRNA is released at 24 h post incubation; whereas at pH = 5.0, recreating the cell endosomal environment, all siRNA molecules are released in about 3 h. These NPs show no cytotoxicity on HeLa cells up to 72 h of incubation. In the same cells, transfected to overexpress AQP1, a silencing efficiency of 70% is achieved at 24 h post treatment with siRNA-loaded NPs. Confocal microscopy analysis of NP uptake demonstrates that siRNA molecules accumulate perinuclearly and in the nucleus. Given the stability, preferential release behavior, and well-known biocompatibility properties of PLGA nanostructures, these siRNA-loaded NPs hold potential for the efficient and safe in vivo silencing of AQPs via systemic administration.


Asunto(s)
Acuaporina 1/genética , Quitosano/química , Ácido Láctico/química , Nanopartículas/química , Ácido Poliglicólico/química , ARN Interferente Pequeño/genética , Células HeLa , Humanos , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Polímeros/química
4.
Biomaterials ; 33(22): 5504-13, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22579236

RESUMEN

Different classes of nanoparticles (NPs) have been developed for controlling and improving the systemic administration of therapeutic and contrast agents. Particle shape has been shown to be crucial in the vascular transport and adhesion of NPs. Here, we use mesoporous silicon non-spherical particles, of disk and rod shapes, ranging in size from 200nm to 1800nm. The fabrication process of the mesoporous particles is described in detail, and their transport and adhesion properties under flow are studied using a parallel plate flow chamber. Numerical simulations predict the hydrodynamic forces on the particles and help in interpreting their distinctive behaviors. Under microvascular flow conditions, for disk-like shape, 1000×400nm particles show maximum adhesion, whereas smaller (600×200nm) and larger (1800×600nm) particles adhere less by a factor of about two. Larger rods (1800×400nm) are observed to adhere at least 3 times more than smaller ones (1500×200nm). For particles of equal volumes, disks adhere about 2 times more than rods. Maximum adhesion for intermediate sized disks reflects the balance between adhesive interfacial interactions and hydrodynamic dislodging forces. In view of the growing evidence on vascular molecular heterogeneity, the present data suggests that thin disk-like particles could more effectively target the diseased microvasculature as compared to spheres and slender rods.


Asunto(s)
Microvasos/química , Microvasos/fisiología , Modelos Cardiovasculares , Nanocápsulas/química , Nanocápsulas/ultraestructura , Reología/métodos , Silicio/química , Animales , Velocidad del Flujo Sanguíneo , Simulación por Computador , Humanos , Ensayo de Materiales , Tamaño de la Partícula , Resistencia al Corte , Enfermedades Vasculares/tratamiento farmacológico , Enfermedades Vasculares/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...